Tech Company Financing Transactions
GEMMABio Funding Round
Advanced Research Projects Agency for Health (ARPA-H) participated in a venture round for GEMMABio. The financing round was announced on 7/9/2026.
Transaction Overview
Company Name
Announced On
7/9/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
This award will support the Regional-bAsed Personalized medIcines Development (RAPID) project to test new AI-designed base-editing systems.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
125 S. 31st St.
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases. Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Wilson
Browse more venture capital transactions:
Prev: 7/9/2026: Dropla Tech venture capital transaction
Next: 7/9/2026: Nscale venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs